According to Seagen 's latest financial reports the company's total debt is $0.11 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $43.47 M | -23.28% |
2021-12-31 | $56.66 M | -24.08% |
2020-12-31 | $74.63 M | -3.14% |
2019-12-31 | $77.05 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $70.84 B | 62,325.65% | ๐บ๐ธ USA |
AbbVie ABBV | $59.38 B | 52,227.58% | ๐บ๐ธ USA |
Biogen BIIB | $7.33 B | 6,366.12% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $41.46 B | 36,436.34% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $22.93 B | 20,111.04% | ๐ฌ๐ง UK |
Spectrum Pharmaceuticals
SPPI | $28.84 M | -74.59% | ๐บ๐ธ USA |
ImmunoGen
IMGN | $84.33 M | -25.69% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $2.54 M | -97.76% | ๐บ๐ธ USA |